CORRECTION: Newsletter December 2023 – Summing up the year with a Christmas message and Cline’s bright view of the future
In our Newsletter published on 7TH December 2023, a section was included related to AstraZeneca BioVentureHub. This was not officially sanctioned by the AstraZeneca BioVentureHub and thus is not to be included. We therefore ask you to disregard this part and replace it with the new version that follows. We apologize for any trouble this may have caused. “Dear investors, Since this past summer, Cline has been in a state of constant change and adaptation. The global financial situation and internal changes have taken up our efforts and then some. That combined with my legal